{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:33:13Z","timestamp":1779337993587,"version":"3.51.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jcte.2019.100190","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T11:50:09Z","timestamp":1555069809000},"page":"100190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Hyperthyroidism in the pregnant woman: Maternal and fetal aspects"],"prefix":"10.1016","volume":"16","author":[{"given":"Mariacarla","family":"Moleti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Sturniolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Vermiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2019.100190_b0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","article-title":"Hyperthyroidism in pregnancy","volume":"1","author":"Cooper","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0010","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1210\/jc.2014-3588","article-title":"Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study","volume":"100","author":"Andersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.AOG.0000197991.64246.9a","article-title":"Subclinical hyperthyroidism and pregnancy outcomes","volume":"107","author":"Casey","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcte.2019.100190_b0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1210\/er.2009-0041","article-title":"Thyroid function and human reproductive health","volume":"31","author":"Krassas","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jcte.2019.100190_b0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/thy.2017.0425","article-title":"Maternal thyroid function in early pregnancy and child neurodevelopmental disorders: a danish nationwide case-cohort study","volume":"28","author":"Andersen","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0030","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/142413","article-title":"Transient non-autoimmune hyperthyroidism of early pregnancy","volume":"2011","author":"Goldman","year":"2011","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.jcte.2019.100190_b0035","first-page":"16","article-title":"Toxic multinodular goiter in the elderly","volume":"25","author":"Vitti","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jcte.2019.100190_b0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4158\/EP13341.RA","article-title":"Thyroid physiology in pregnancy","volume":"20","author":"Moleti","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jcte.2019.100190_b0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/thy.1995.5.425","article-title":"Thyrotropic action of human chorionic gonadotropin","volume":"5","author":"Yoshimura","year":"1995","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0050","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1089\/thy.2004.14.1084","article-title":"Trimester specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency","volume":"14","author":"Soldin","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/thy.1999.9.19","article-title":"Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders","volume":"9","author":"Vermiglio","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0060","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/jc.2008-0352","article-title":"Iodine prophylaxis using iodized salt and risk of maternal thyroid failure in conditions of mild iodine deficiency","volume":"93","author":"Moleti","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/aot.2018.07.03","article-title":"Autoimmune thyroid diseases and pregnancy","volume":"3","author":"Moleti","year":"2018","journal-title":"Ann Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0070","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrendo.2010.91","article-title":"Serum TSH determinations in pregnancy: how, when and why?","volume":"6","author":"Glinoer","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0080","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0002-9378(11)91565-8","article-title":"Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects","volume":"167","author":"Goodwin","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcte.2019.100190_b0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2265.1998.00540.x","article-title":"Gestational transient hyperthyroxinaemia (GTH): screening for thyroid function in 23163 pregnant women using dried blood spots","volume":"49","author":"Tanaka","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2265.2001.01353.x","article-title":"Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin","volume":"55","author":"Yeo","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0095","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2265.1997.2011011.x","article-title":"The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies","volume":"46","author":"Gr\u00fcn","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2019.100190_b0100","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1089\/thy.2009.0079","article-title":"Serum human chorionic gonadotropin concentrations greater than 400,000 IU\/L are invariably associated with suppressed serum thyrotropin concentrations","volume":"19","author":"Lockwood","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0105","first-page":"70","article-title":"Increased in vitro thyrotropic activity of partially sialated human chorionic gonadotropin extracted from hydatidiform moles of patients with hyperthyroidism","volume":"76","author":"Pekary","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0110","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM199812173392505","article-title":"Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin","volume":"339","author":"Rodien","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2019.100190_b0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00003081-199809000-00014","article-title":"Hyperemesis gravidarum","volume":"41","author":"Goodwin","year":"1998","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jcte.2019.100190_b0120","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMcp1003896","article-title":"Nausea and vomiting in pregnancy","volume":"363","author":"Niebyl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2019.100190_b0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000477853","article-title":"Hyperemesis gravidarum: a review of recent literature","volume":"100","author":"London","year":"2017","journal-title":"Pharmacology"},{"key":"10.1016\/j.jcte.2019.100190_b0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humupd\/dmh008","article-title":"Abnormal stimulation of the thyrotrophin receptor during gestation","volume":"10","author":"Rodien","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jcte.2019.100190_b0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13044-017-0039-0","article-title":"Comparative frequency of four different types of pregnancy-associated thyrotoxicosis in a single thyroid centre","volume":"10","author":"Ide","year":"2017","journal-title":"Thyroid Res"},{"key":"10.1016\/j.jcte.2019.100190_b0140","first-page":"284","article-title":"Increased serum reverse triiodothyronine in patients with hyperemesis gravidarum","volume":"102","author":"Juras","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.jcte.2019.100190_b0145","first-page":"404","article-title":"Thyroid function in hyperemesis gravidarum","volume":"111","author":"Bober","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.jcte.2019.100190_b0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004049900052","article-title":"Severity of hyperemesis gravidarum correlates with serum levels of reverse T3","volume":"264","author":"Asakura","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jcte.2019.100190_b0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1507\/endocrj.EJ14-0596","article-title":"Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?","volume":"62","author":"Yoshihara","year":"2015","journal-title":"Endocr J"},{"issue":"11","key":"10.1016\/j.jcte.2019.100190_b0160","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF03348950","article-title":"Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy","volume":"16","author":"Glinoer","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jcte.2019.100190_b0165","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/bjc.2011.139","article-title":"Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease","volume":"104","author":"Walkington","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcte.2019.100190_b0170","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/0002-9378(89)90307-4","article-title":"Maternal weight loss associated with hyperemesis gravidarum: a predictor of fetal outcome","volume":"160","author":"Gross","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcte.2019.100190_b0175","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrendo.2010.46","article-title":"Immunity, thyroid function and pregnancy: molecular mechanisms","volume":"6","author":"Weetman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"Aluvihare","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcte.2019.100190_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12595","article-title":"The T helper type 17\/ regulatory T cell paradigm in pregnancy","volume":"148","author":"Figueiredo","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.jcte.2019.100190_b0190","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bpobgyn.2015.04.007","article-title":"Thyroid disorders during pregnancy and postpartum","volume":"29","author":"Pearce","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jcte.2019.100190_b0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-55-1-108","article-title":"Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease","volume":"55","author":"Amino","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/thy.1993.3.189","article-title":"Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease","volume":"3","author":"Tamaki","year":"1993","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0205","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.39462.709005.AE","article-title":"Hyperthyroidism and pregnancy","volume":"336","author":"Marx","year":"2008","journal-title":"Brit Med J"},{"key":"10.1016\/j.jcte.2019.100190_b0210","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1210\/jc.2004-2555","article-title":"Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring","volume":"90","author":"Luton","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fendo.2017.00137","article-title":"Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance","volume":"8","author":"Bucci","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcte.2019.100190_b0220","first-page":"140","article-title":"Thyrotoxicosis of Pregnancy","volume":"1","author":"Labadzhyan","year":"2014","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0225","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1210\/jc.2008-0966","article-title":"The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy","volume":"93","author":"Rotondi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-08-0663","article-title":"Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy","volume":"160","author":"Laurberg","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0235","first-page":"74","article-title":"Thyroid storm during pregnancy","volume":"24","author":"Waltman","year":"2004","journal-title":"A medical emergency Crit Care Nurse"},{"key":"10.1016\/j.jcte.2019.100190_b0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/aot.2018.10.02","article-title":"A look at Graves\u2019 hyperthyroidism in pregnancy","volume":"3","author":"Nguyen","year":"2018","journal-title":"Ann Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9378(03)00944-X","article-title":"Thyrotoxicosis and heart failure that complicate pregnancy","volume":"190","author":"Sheffield","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcte.2019.100190_b0250","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.292.6.691","article-title":"Fetal loss associated with excess thyroid hormone exposure","volume":"292","author":"Anselmo","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jcte.2019.100190_b0255","first-page":"946","article-title":"Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism","volume":"84","author":"Millar","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcte.2019.100190_b0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00404-010-1362-z","article-title":"Outcomes of pregnancy complicated with hyperthyroidism: a cohort study","volume":"283","author":"Luewan","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jcte.2019.100190_b0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/thy.1992.2.219","article-title":"Diagnosis and management of Graves\u2019 disease in pregnancy","volume":"2","author":"Hamburger","year":"1992","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9378(89)90088-4","article-title":"Thyrotoxicosis complicating pregnancy","volume":"160","author":"Davis","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcte.2019.100190_b0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000365101","article-title":"Spontaneous abortion, stillbirth and hyperthyroidism: a danish population-based study","volume":"3","author":"Andersen","year":"2014","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jcte.2019.100190_b0280","doi-asserted-by":"crossref","first-page":"E2591","DOI":"10.1210\/jc.2014-1505","article-title":"Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study","volume":"99","author":"Medici","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0285","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/thy.2014.0434","article-title":"Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system","volume":"25","author":"Lo","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0290","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2265.2001.01173.x","article-title":"Congenital thyrotoxicosis in premature infants","volume":"54","author":"Smith","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2019.100190_b0295","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/thy.2017.0413","article-title":"Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: a systematic review","volume":"28","author":"van Dijk","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0300","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/thy.1998.8.1171","article-title":"Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism","volume":"8","author":"Polak","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0305","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.beem.2004.03.009","article-title":"Fetal and neonatal thyroid function in relation to maternal Graves' disease","volume":"18","author":"Polak","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0310","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/thy.1999.9.727","article-title":"Fetal and neonatal hyperthyroidism","volume":"9","author":"Zimmerman","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0315","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1586\/1744666X.2015.1054375","article-title":"Important considerations in the management of Graves' disease in pregnant women","volume":"11","author":"Okosieme","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jcte.2019.100190_b0320","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1203\/00006450-199708000-00014","article-title":"The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves\u2019 disease","volume":"42","author":"Matsuura","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcte.2019.100190_b0325","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jcem.86.6.7573","article-title":"The use of antithyroid drugs in pregnancy and lactation","volume":"86","author":"Mandel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/14740338.5.1.107","article-title":"The safety and efficacy of antithyroid drugs","volume":"5","author":"Azizi","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jcte.2019.100190_b0335","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/thy.2014.0150","article-title":"Severity of birth defects after propylthiouracil exposure in early pregnancy","volume":"24","author":"Andersen","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0340","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European thyroid association guideline for the management of Graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jcte.2019.100190_b0345","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrendo.2011.34","article-title":"Antithyroid drug-induced fetal goitrous hypothyroidism","volume":"7","author":"Bliddal","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0350","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-45-6-1187","article-title":"The placental transfer of propylthiouracil, methimazole and carbimazole","volume":"45","author":"Marchant","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0355","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","author":"Mortimer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0360","first-page":"3633","article-title":"Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism","volume":"82","author":"Momotani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0365","first-page":"186","article-title":"Treatment of maternal hyperthyroidism with antithyroid agents and changes in thyrotrophin and thyroxine in the newborn","volume":"97","author":"Lamberg","year":"1981","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.jcte.2019.100190_b0370","first-page":"359","article-title":"Risk factors for developmental disorders in infants born to women with Graves disease","volume":"80","author":"Mitsuda","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcte.2019.100190_b0375","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2265.1989.tb01283.x","article-title":"Recovery from foetal hypothyroidism: evidence for the safety of breast-feeding while taking propylthiouracil","volume":"31","author":"Momotani","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2019.100190_b0380","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198102263040907","article-title":"Neonatal thyroid function after propylthiouracil therapy for maternal Graves\u2019 disease","volume":"304","author":"Cheron","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2019.100190_b0385","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/jcem-62-1-217","article-title":"Cooper DS Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests","volume":"62","author":"Gardner","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0390","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198607033150104","article-title":"Antithyroid drug therapy for Graves\u2019 disease during pregnancy. Optimal regimen for fetal thyroid status","volume":"315","author":"Momotani","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2019.100190_b0395","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1210\/jc.2010-0652","article-title":"Treatment of hyperthyroidism in pregnancy and birth defects","volume":"95","author":"Clementi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0400","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ajmg.a.33705","article-title":"Grade 1 microtia, wide anterior fontanel and novel type tracheo-esophageal fistula in methimazole embryopathy","volume":"155A","author":"Gripp","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jcte.2019.100190_b0405","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of graves\u2019 disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0410","article-title":"Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis","volume":"12","author":"Song","year":"2017","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.jcte.2019.100190_b0415","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"Andersen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0420","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40618-015-0281-z","article-title":"Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy","volume":"38","author":"Gianetti","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jcte.2019.100190_b0425","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/thy.2012.0488","article-title":"Prevalence of thyrotoxicosis, anti-thyroid medication use, and complications among pregnant women in the United States","volume":"23","author":"Korelitz","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0430","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/EJE-17-0314","article-title":"Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study","volume":"177","author":"Andersen","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0435","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/17512433.2017.1253471","article-title":"Current challenges in the pharmacological management of thyroid dysfunction in pregnancy","volume":"10","author":"Khan","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jcte.2019.100190_b0440","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm209023.htm (accessed Feb 24, 2019)."},{"key":"10.1016\/j.jcte.2019.100190_b0445","first-page":"738","article-title":"Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy","volume":"75","author":"Momotani","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2019.100190_b0450","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/thy.2014.0581","article-title":"Substituting potassium iodide for methimazole as the treatment for Graves' disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan","volume":"25","author":"Yoshihara","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0455","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2019.100190_b0460","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/thy.2018.0165","article-title":"Incidence of neonatal hyperthyroidism among newborns of graves' disease patients treated with radioiodine therapy","volume":"1","author":"Yoshihara","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2019.100190_b0465","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000336101","article-title":"Management of hyperthyroidism in pregnancy: results of a survey among members of the european thyroid association","volume":"1","author":"Poppe","year":"2012","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jcte.2019.100190_b0470","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(15)00327-7","article-title":"Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study","volume":"4","author":"Korevaar","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"updated-by":[{"DOI":"10.1016\/j.jcte.2020.100246","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623719300304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623719300304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:55:48Z","timestamp":1762005348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623719300304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":94,"alternative-id":["S2214623719300304"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2019.100190","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperthyroidism in the pregnant woman: Maternal and fetal aspects","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2019.100190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100190"}}